BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, announced its Chairman Kenneth L. Londoner will be presenting at the Monaco Growth Forums from February 20th – 23rd in United Arab Emirates, Dubai and Abu Dhabi, at The Ritz-Carlton in Abu Dhabi, and The Ritz-Carlton Jumeirah Beach Residence in Dubai.

The Company will conduct a corporate presentation and discuss recent business highlights to a number of institutional investment firms in the Dubai region. This exclusive three-day event will allow top emerging growth companies and established institutional investors, and industry professionals, the unique opportunity to network with one another.

Mr. Londoner, the Chairman of BioSig Technologies commented, ” We look forward to exploring business development opportunities with potential distribution partners in the U.A.E. region. Their strong bias towards emerging medical technologies is of particular interest to us as we develop an international market for our product.”


About BioSig Technologies
BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System.